-
FEATURED
Physician business owners discuss direct care models and their future in rheumatology
Direct care, concierge medicine, wellness, and coaching models are changing the ways rheumatologists practice and patients experience care. Diana Girnita, MD, PhD, discussed the potential of direct care and addressed some of the common fears providers have related to this approach to serving patients. READ MORE
#ACR22 SESSION COVERAGE
-
Social media can facilitate connections and collaboration to advance rheumatology
At events like ACR Convergence, social media helps enhance engagement among attendees. It also can be used to amplify one’s own work and as a research tool. Jean Liew, MD, MS, shared her expertise with social media and how the COVID-19 Global Rheumatology Alliance used it to benefit the field. READ MORE
-
Panel outlines ACR Workforce Solutions Committee initiatives
The Association of American Medical Colleges estimates a shortage of as many as 139,000 physicians by 2033. ACR Workforce Solutions Committee Chair Daniel Battafarano, DO, outlined the types of projects committee members will undertake to improve the practice of rheumatology for providers and patients and combat the workforce shortage. READ MORE
-
Proposed classification criteria for pediatric CNO and CRMO explained
Recently developed classification criteria for pediatric chronic nonbacterial osteomyelitis (CNO) and chronic recurrent multifocal osteomyelitis (CRMO) await ACR and EULAR endorsement. Yongdong “Dan” Zhao, MD, PhD, RhMSUS, explained how point values are assigned for each of the 10 criteria. READ MORE
-
Experts share best practices and recent insights to improve care for Sjögren’s syndrome
Experts including Alen Zabotti, MD, reviewed a variety of methods to identify, prevent, and manage Sjögren’s syndrome. Dr. Zabotti discussed the assessment of glandular involvement in primary Sjögren’s syndrome through biopsy and imaging. READ MORE
-
ACR advocacy outlines legislative priorities, how members can get involved
The ACR Government Affairs Committee (GAC) and the political action committee, RheumPAC, promote legislation that allows clinicians to stay focused on patient care. GAC Chair Blair Solow, MD, MSc, explained the committee’s current priorities. READ MORE
-
Trans-omic technologies bring new insights into immune-mediated disease pathology
In a joint session of the ACR and the Japan College of Rheumatology, experts including Keishi Fujio, MD, PhD, discussed recent advances in omic technology that pave the way for novel approaches to the translation of basic science discoveries into clinical rheumatology. READ MORE
POSTER SPOTLIGHT
-
Kristin Wipfler, PhD: Impact on Access to Methotrexate in the Post-Roe Era
Kristin Wipfler, PhD, will discuss the poster “Impact on Access to Methotrexate in the Post-Roe Era” in a Monday afternoon Ignite Talk. READ MORE
-
Matthew C. Baker, MD, MS: Sarcoidosis Incidence after mTOR Inhibitor Treatment
Kristin Wipfler, PhD, will discuss the poster “Impact on Access to Methotrexate in the Post-Roe Era” in a Monday afternoon Ignite Talk. READ MORE
-
Robert M. Hamilton, MD, MHSc, FRCP(C): Fetal Cardiac Targets Identify the Autoantibodies Associated with Congenital Heart Block
Robert M. Hamilton, MD, MHSc, FRCP(C), will discuss the poster “Fetal Cardiac Targets Identify the Autoantibodies Associated with Congenital Heart Block” in a Monday afternoon Ignite Talk. READ MORE
-
Sabine Sparre Dieperink, MD: The Increased Risk of Staphylococcus Aureus Bacteremia in Rheumatoid Arthritis – What Is the Impact of Glucocorticoids, Biologic Disease-Modifying Anti-Rheumatic Drugs and Disease Activity: A Danish Nationwide Nested Case-Control Study in the DANBIO Registry
Sabine Sparre Dieperink, MD, will discuss the poster “The Increased Risk of Staphylococcus Aureus Bacteremia in Rheumatoid Arthritis – What Is the Impact of Glucocorticoids, Biologic Disease-Modifying Anti-Rheumatic Drugs and Disease Activity: A Danish Nationwide Nested Case-Control Study in the DANBIO Regis” in a Monday afternoon Ignite Talk. READ MORE